Bibliographic information

GuidelineMedical eligibility criteria for contraceptive use, 6th ed.
Year of Publication2025
Issuing InstitutionWorld Health Organization

Recommendation

Updated

Women living with asymptomatic or mild HIV clinical disease (WHO stage 1 or 2) who are using Nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs) can generally have an levonorgestrel-intrauterine device inserted

Notes and Remarks

There is no known interaction between ART and IUD use